Grifols SA (GRFS)
8.72
+0.03
(+0.35%)
USD |
NASDAQ |
Nov 16, 16:00
8.72
0.00 (0.00%)
After-Hours: 20:00
Grifols Price : 8.72 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 8.775 | 8.81 | 8.685 | 8.69 | 312712.0 |
| Nov 12, 2026 | 8.85 | 8.89 | 8.69 | 8.80 | 738238.0 |
| Nov 11, 2026 | 8.68 | 8.88 | 8.595 | 8.84 | 724577.0 |
| Nov 10, 2026 | 8.64 | 8.78 | 8.60 | 8.76 | 1.045M |
| Nov 09, 2026 | 8.53 | 8.815 | 8.44 | 8.69 | 1.186M |
| Nov 06, 2026 | 8.30 | 8.55 | 8.26 | 8.43 | 610345.0 |
| Nov 05, 2026 | 8.60 | 8.61 | 8.315 | 8.46 | 761428.0 |
| Nov 04, 2026 | 8.63 | 8.645 | 8.38 | 8.61 | 674599.0 |
| Nov 03, 2026 | 8.56 | 8.72 | 8.405 | 8.56 | 1.003M |
| Nov 02, 2026 | 8.30 | 8.58 | 8.25 | 8.51 | 1.587M |
| Oct 30, 2026 | 8.10 | 8.249 | 8.05 | 8.10 | 803383.0 |
| Oct 29, 2026 | 8.12 | 8.14 | 7.995 | 8.04 | 273389.0 |
| Oct 28, 2026 | 7.95 | 8.30 | 7.90 | 8.12 | 969082.0 |
| Oct 27, 2026 | 7.89 | 8.13 | 7.88 | 8.10 | 840517.0 |
| Oct 26, 2026 | 7.76 | 8.11 | 7.76 | 7.92 | 845888.0 |
| Oct 23, 2026 | 7.50 | 7.569 | 7.491 | 7.56 | 992340.0 |
| Oct 22, 2026 | 7.42 | 7.49 | 7.37 | 7.45 | 482548.0 |
| Oct 21, 2026 | 7.51 | 7.59 | 7.48 | 7.50 | 310897.0 |
| Oct 20, 2026 | 7.61 | 7.695 | 7.52 | 7.54 | 369081.0 |
| Oct 19, 2026 | 7.52 | 7.67 | 7.50 | 7.64 | 1.464M |
| Oct 16, 2026 | 7.59 | 7.75 | 7.57 | 7.64 | 872360.0 |
| Oct 15, 2026 | 7.51 | 7.56 | 7.40 | 7.54 | 907080.0 |
| Oct 14, 2026 | 7.29 | 7.40 | 7.22 | 7.24 | 538498.0 |
| Oct 13, 2026 | 7.36 | 7.36 | 7.15 | 7.17 | 439513.0 |
| Oct 12, 2026 | 7.52 | 7.52 | 7.36 | 7.37 | 266106.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.155 |
| Evaxion AS | 2.85 |
| DBV Technologies SA | 10.30 |
| Cellectis SA | 1.03 |
| Akari Therapeutics Plc | 6.40 |
Price Related Metrics
| PE Ratio | 10.50 |
| PS Ratio | 0.6727 |
| PEG Ratio | 0.2978 |
| Price to Book Value | 0.9027 |
| Price to Free Cash Flow | 7.759 |
| Earnings Yield | 9.52% |
| Market Cap | 2.252B |
| PEGY Ratio | 0.2727 |
| Operating PE Ratio | 4.101 |
| Normalized PE Ratio | 10.50 |